(Press-News.org) Small models, big insights into vision
Understanding how the brain processes what we see is one of the central questions in neuroscience. Our visual system is incredibly powerful, able to recognize faces, objects, and scenes with ease, yet the details of how individual neurons respond to images remain complex and difficult to study. A new study published in Nature shows that it is possible to capture these responses using models that are both highly accurate and far simpler than previous approaches.
The team began with a large computer model designed to predict how neurons in the visual cortex of non-human subjects respond to images. While this model was very precise, it was also enormous, with millions of parameters, making it almost as hard to understand as the brain itself. Using advanced machine learning techniques, the researchers compressed this model, creating smaller versions that were thousands of times simpler while still predicting neural responses with high accuracy. These compact models allowed the team to examine the inner workings of the visual system in a way that was previously impossible.
“This work shows that we don’t need massive, complicated networks to understand what individual neurons are doing,” explained Matt Smith, professor of biomedical engineering and Neuroscience Institute at Carnegie Mellon University. “By making the models smaller and interpretable, we can actually gain intuition about how the visual system works and develop hypotheses that can be tested in the lab.”
One surprising finding was that even though the model was dramatically reduced in size, it could still capture subtle differences in how neurons respond to similar images. This suggests that the brain’s visual system relies on specific computational patterns that can be represented in a more straightforward way than previously thought. By studying these simplified models, researchers could see how individual neurons detect important features, such as the eyes in a face or the dots in a pattern, offering insights into how visual information is processed at a fine scale.
Beyond helping scientists understand vision, this research also has implications for technology. Modern computer vision systems, like those that recognize faces on a phone or guide self-driving cars, were inspired by the brain but often fail in subtle ways that humans easily handle. Insights from these compact neural models could help improve artificial intelligence systems, making them more robust and adaptable in real-world situations.
“The study also highlights the collaborative nature of this research, combining experimental neuroscience with computational modeling and machine learning,” Smith added. “By working together across institutions and disciplines, we were able to build models that are not only predictive, but also interpretable and meaningful.”
Looking ahead, the researchers are extending these models to account for time, moving from single images to sequences like videos. This could help explain how the visual system tracks movement, recognizes changing patterns, and focuses on important details in dynamic environments. By continuing to simplify and study these models, the collaborators hope to uncover rules that govern how our brains interpret the world around us.
END
Small models, big insights into vision
2026-02-25
ELSE PRESS RELEASES FROM THIS DATE:
Finding new ways to kill bacteria
2026-02-25
The scientists report their findings in the February 26 issue of the journal Nature. The lead author of the paper is Yancheng Evelyn Li, a graduate student in the lab of Bil Clemons, the Arthur and Marian Hanisch Memorial Professor of Biochemistry at Caltech, who is the corresponding author.
"Evolution is powerful, and in bacteria, resistance to antibiotics develops quickly. This means that we now deal with bacteria that are resistant to all the medicines that we have," Clemons says. "In the USA alone, tens of thousands of people die every year from antibiotic-resistant bacterial infections, ...
An endangered natural pharmacy hidden in coral reefs
2026-02-25
Coral reefs are teeming with life: they are home to over a third of all marine animal and plant species on Earth, despite covering less than one percent of the ocean floor. However, this immense diversity is under threat from rising ocean temperatures. Since the 1950s, half of the world’s coral population has already disappeared.
Beyond the reef’s visible inhabitants, countless microorganisms are also under threat. These often live in symbiosis with corals, sponges and other reef dwellers, which benefits them ...
The Frontiers of Knowledge Award goes to Charles Manski for incorporating uncertainty into economic research and its application to public policy analysis
2026-02-25
The BBVA Foundation Frontiers of Knowledge Awards in Economics, Finance and Management has gone in this eighteenth edition to Charles F. Manski for his pioneering contributions to the measurement of uncertainty in economic research and its application to public policy analysis. The professor at Northwestern University (Chicago, United States) is described by the committee as a “foundational figure” in the development of modern methods that have transformed how economists infer conclusions from data, report degrees of uncertainty in their models, ...
Walter Koroshetz joins Dana Foundation as senior advisor
2026-02-25
NEW YORK, February 24, 2026 – The Dana Foundation today announced Walter Koroshetz, M.D., FAAN, will join the organization as a senior advisor, effective March 1, in support of its mission to advance neuroscience that benefits society and reflects the aspirations of all people. Koroshetz, who oversaw the federal government’s largest neuroscience research portfolio as director of the National Institute of Neurological Disorders and Stroke (NINDS), will work with the Foundation’s leadership to guide science funding collaborations and support for early-career scholars and ...
Next-generation CAR-T designs that could transform cancer treatment
2026-02-25
“CAR T-cell therapy has emerged as a particularly promising cancer-specific treatment strategy.”
BUFFALO, NY – February 25, 2026 – A new editorial perspective was published in Volume 17 of Oncotarget on February 20, 2026, titled “CAR-T therapy: Trailblazing CAR(ing) in cancer treatment.”
Led by Uzma Saqib — with corresponding author Krishnan Hajela from the School of Life Sciences, Devi Ahilya Vishwavidyalaya — the perspective reviews recent clinical and translational advances in chimeric antigen receptor T-cell (CAR-T) therapy and highlights both its promise ...
As health care goes digital, patients are being left behind
2026-02-25
Patients are now expected to navigate much of their care online — from seeing their doctor on a screen to booking appointments, refilling prescriptions, and checking test results through health care portals.
Yet, according to a new study by UC San Francisco, most health systems are skipping a crucial step: asking whether their patients have the access and skills to use these digital tools.
The researchers surveyed nearly 150 clinicians and informatics leaders from health care systems across the country during the first half of 2024. Just 44% said they asked their patients if they could use digital devices. Among the ...
A clinicopathologic analysis of 740 endometrial polyps: risk of premalignant changes and malignancy
2026-02-25
Background and objectives
Endometrial polyp (EMP) is one of the most common diagnoses in the evaluation of women with abnormal uterine bleeding. Understanding the malignancy risk associated with EMPs and related risk factors is essential for guiding both pathology practice and clinical management. This study aimed to explore risk factors for malignancy in EMPs.
Methods
The pathology database was searched for women diagnosed with EMP between 2021 and 2022. Patient age, polyp size, background endometrium, recurrence, and (if applicable) cancer types were recorded. Immunohistochemistry (IHC) for p53 and p16 was performed on selected cases. Risk factors for malignancy were analyzed using Chi-square ...
Gibson Oncology, NIH to begin Phase 2 trials of LMP744 for treatment of first-time recurrent glioblastoma
2026-02-25
WEST LAFAYETTE, Ind. and MIAMI — Gibson Oncology, a clinical-stage private pharmaceutical company headquartered in Miami, announced it has entered Phase 2 clinical trials with LMP744 for the treatment of first-time recurrent glioblastoma patients.
The company is focused on advancing its novel small molecules with dual-action inhibition of topoisomerase 1 and reduction of overexpression of the cMYC oncogene.
“The primary endpoint of the study is to evaluate tumor regression in patients with recurrent glioblastoma. Secondary endpoints will evaluate parameters such as progression-free survival, biological changes in glioblastoma tissues obtained pre- and post-treatment, ...
Researchers develop a high-efficiency photocatalyst using iron instead of rare metals
2026-02-25
Photocatalysts facilitate chemical reactions by absorbing light. Metal-based photocatalysts are widely used in organic synthesis due to their durability and the ability to tune their function by modifying the ligands attached to the central metal atom.
Most metals used in photocatalysts, such as ruthenium and iridium, are rare and expensive. Researchers at Nagoya University, Japan, previously developed an iron-based alternative, but it required large amounts of costly chiral ligands, which act as spatial ...
Study finds no evidence of persistent tick-borne infection in people who link chronic illness to ticks
2026-02-25
When researchers studied Norwegians who thought tick bites caused their chronic health problems, they found no objective evidence linking the symptoms to ticks.
The same study finds that health problems reported by participants were associated with little physical activity and low labour force participation.
Many Norwegians pull ticks from their bodies every single summer. Roughly 2 per cent of those who are bitten are infected by a bacterium that leads to Lyme disease.
The disease can start with a rash that eventually spreads in the skin with a ring-shaped pattern. In some people, the disease can develop into facial paralysis, meningitis or other ...